Fortress Biotech, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:FBIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -19.56 M-27.56 M-6.11 M-12.54 M203.85 M 157.64 M Cash from investing activities 1.17 M6.09 M2.87 M00 8.96 M Cash from financing activities 52.14 M4.52 M15.07 M5.71 M-27.39 M -2.09 M Free cash flow -19.56 M-27.56 M-6.11 M-12.54 M203.85 M 157.64 M

News

Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)

Avenue Therapeutics licenses ATX-04 for Pompe disease treatment

Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

FDA approves first treatment for Menkes disease in children

FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates

Kamada (KMDA) Misses Q3 Earnings Estimates